ITCMDBv1
Clinical TrialID 5215

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

NCT00152230

Colorectal Cancer

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
5215
Evidence Id
5215
Core Evidence Id
5215
Source Clinical Trial Id
5197
Herb2 Clinical Trial Id
HBCT005197
Nct Id
NCT00152230
Title
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
Status
Completed
Phase
Phase 3
Study Result
No
Study Condition
Colorectal Cancer
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: UFT (uracil, tegafur)|PROCEDURE: Surgery alone
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
900
Outcome Measure
Relapse-free survival and overall survival, every course for first three courses, then every other course
Sponsor Collaborator
Taiho Pharmaceutical Co., Ltd.
Funded By
INDUSTRY
Location
National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
Other Id
1023002
Start Date
1996-10
Primary Completion Date
2006-03
Completion Date
2008-02
First Posted
2005-09-09
Results First Posted
Last Update Posted
2011-07-07
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00152230
Title Cn
Title En
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
Bilingual Status
semi_complete